6BremerBM, CooperME, de Zeeum, et al. Effects of Losartan on renal and cardiovascular octcomes in patients with type 2 diabetes and nephropathy. New Eng J Med, 2001,345 (12) : 861-869.
7Derubertis FR, Craven PA. Activation of protein Kinase Cin glomerular cell in diabetes mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes, 1994,43; 1-2.
8Monterroso VH, Rodriguez CV, Carbajal ET, et al. Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin Ⅱ receptor antagonists, Losartan and valsartan. Losartan Trial Investigators. Adv Ther, 2000, 17 ( 2 ) :117-131.
9Zope C, Remuzzi G. Role of platelets in progressive golmeruler disease, Pediatr Nephrol, 1995,495-502.
